A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patientsFRASCI, Giuseppe; D'AIUTO, Giuseppe; COMELLA, Giuseppe et al.Oncology. 2002, Vol 62, Num 1, pp 25-32, issn 0030-2414Article

Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology GroupDAPONTE, Antonio; ASCIERTO, Paolo A; GRAVINA, Adriano et al.Cancer. 2000, Vol 89, Num 12, pp 2630-2636, issn 0008-543XArticle

Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South ItalyCASULA, Milena; COLOMBINO, Maria; MOZZILLO, Nicola et al.European journal of cancer (1990). 2007, Vol 43, Num 1, pp 137-143, issn 0959-8049, 7 p.Article

Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trialFRASCI, Giuseppe; LORUSSO, Vito; MASCIA, Vittorio et al.Lung cancer. 2001, Vol 34, pp S65-S69, issn 0169-5002, SUP4Conference Paper

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian multicenter, randomized, phase II studyPALMERI, Sergio; LORUSSO, Vito; PALMERI, Laura et al.Cancer. 2006, Vol 107, Num 12, pp 2898-2905, issn 0008-543X, 8 p.Article

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I studyFRASCI, Giuseppe; COMELLA, Pasquale; COMELLA, Giuseppe et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 1, pp 25-32, issn 0344-5704, 8 p.Article

Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients : A phase I/II study of the Southern Italy Cooperative Oncology GroupCOMELLA, Pasquale; BIGLIETTO, Maria; CASARETTI, Rossana et al.Oncology. 2001, Vol 60, Num 2, pp 127-133, issn 0030-2414Article

Biweekly docetaxel-lrinotecan treatment with filgrastim support is highly active in antracycline-paclitaxel-refractory breast cancer patientsFRASCI, Giuseppe; D'AIUTO, Giuseppe; D'ANIELLO, Roberta et al.Oncology. 2005, Vol 68, Num 4-6, pp 391-397, issn 0030-2414, 7 p.Article

Temozolomide and cisplatin in avdanced malignant melanomaDAPONTE, Antonio; ASCIERTO, Paolo Antonio; GRAVINA, Adriano et al.Anticancer research. 2005, Vol 25, Num 2B, pp 1441-1447, issn 0250-7005, 7 p.Article

Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumoursCAPONIGRO, Francesco; AVALLONE, Antonio; RIVELLINI, Flavia et al.Cancer chemotherapy and pharmacology. 2001, Vol 47, Num 2, pp 113-116, issn 0344-5704Article

Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma : A randomized phase III trialDI BARTOLOMEO, Maria; BUZZONI, Roberto; ARDIZZONI, Antonio et al.Oncology. 2006, Vol 71, Num 5-6, pp 341-346, issn 0030-2414, 6 p.Article

Weekly dose-dense cisplatin-epirubicin- paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer : A SICOG phase II studyFRASCI, Giuseppe; COMELLA, Pasquale; D'AIUTO, Massimiliano et al.Oncology. 2005, Vol 68, Num 2-3, pp 223-229, issn 0030-2414, 7 p.Article

Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOQ) phase II studyFRASCI, Giuseppe; D'AIUTO, Giuseppe; D'ANIELLO, Roberta et al.Breast cancer research and treatment. 2000, Vol 62, Num 2, pp 87-97, issn 0167-6806Article